A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus

Far Eastern Memorial Hospital100 enrolled

Overview

An increased prevalence of the metabolic syndrome has been found in patients with systemic lupus erythematosus in recent years.

This study will investigate the prevalence of the metabolic syndrome in patients with SLE in Taiwan. We expect our study will provide further understanding of the association between SLE and metabolic syndrome, which may give direction to prevent late cardiovascular morbidity and mortality in SLE patients.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Metabolic Syndrome Cardiovascular Risk Factors Systemic Lupus Erythematosus

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Persons aged 18 and above. * Persons fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus in the patient group. Exclusion Criteria: * Exclude a history myocardial infarction, angina or stroke.

Locations (1)

Far Eastern Memorial Hospital

Pan-Chiao, Taipei, Taiwan

Outcomes

Primary Outcomes

The prevalence of the metabolic syndrome in patients with systemic lupus erythematosus in Taiwan

Time frame: One year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.